Role of the innate immune system in the pathogenesis of multiple sclerosis
- PMID: 19931190
- PMCID: PMC2854189
- DOI: 10.1016/j.jneuroim.2009.10.015
Role of the innate immune system in the pathogenesis of multiple sclerosis
Abstract
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease with heterogeneous clinical presentations and course. MS is considered to be a T cell mediated disease but in recent years contribution of innate immune cells in mediating MS pathogenesis is being appreciated. In this review, we have discussed the role of various innate immune cells in mediating MS. In particular, we have provided an overview of potential anti-inflammatory or pro-inflammatory function of DCs, microglial Cells, NK cells, NK-T cells and gamma delta T cells along with their interaction among themselves and with myelin. Given the understanding of the role of the innate immune cells in MS, it is possible that immunotherapeutic intervention targeting these cells may provide a better and effective treatment.
Copyright 2009 Elsevier B.V. All rights reserved.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2854189/bin/nihms157054f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2854189/bin/nihms157054f2.gif)
Similar articles
-
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.Cell Mol Immunol. 2019 Jun;16(6):531-539. doi: 10.1038/s41423-019-0221-5. Epub 2019 Mar 15. Cell Mol Immunol. 2019. PMID: 30874627 Free PMC article. Review.
-
Infections in MS: An innate immunity perspective.Acta Neurol Scand. 2017 Nov;136 Suppl 201:10-14. doi: 10.1111/ane.12838. Acta Neurol Scand. 2017. PMID: 29068495 Review.
-
The innate immune system in demyelinating disease.Immunol Rev. 2012 Jul;248(1):170-87. doi: 10.1111/j.1600-065X.2012.01135.x. Immunol Rev. 2012. PMID: 22725961 Free PMC article. Review.
-
Role of the innate immune system in autoimmune inflammatory demyelination.Curr Med Chem. 2008;15(11):1105-15. doi: 10.2174/092986708784221458. Curr Med Chem. 2008. PMID: 18473806 Review.
-
The role of CD4 T cells in the pathogenesis of multiple sclerosis.Int Rev Neurobiol. 2007;79:43-72. doi: 10.1016/S0074-7742(07)79003-7. Int Rev Neurobiol. 2007. PMID: 17531837 Free PMC article. Review.
Cited by
-
Breaking boundaries: the transformative role of exercise in managing multiple sclerosis.EXCLI J. 2024 Apr 15;23:475-490. doi: 10.17179/excli2024-6932. eCollection 2024. EXCLI J. 2024. PMID: 38741722 Free PMC article. Review.
-
Inflammasome Molecular Insights in Autoimmune Diseases.Curr Issues Mol Biol. 2024 Apr 18;46(4):3502-3532. doi: 10.3390/cimb46040220. Curr Issues Mol Biol. 2024. PMID: 38666950 Free PMC article. Review.
-
Interferon Lambda Signaling Restrains Experimental Autoimmune Encephalomyelitis.Biomedicines. 2024 Feb 26;12(3):526. doi: 10.3390/biomedicines12030526. Biomedicines. 2024. PMID: 38540139 Free PMC article.
-
The Impact of Cytomegalovirus Infection on Natural Killer and CD8+ T Cell Phenotype in Multiple Sclerosis.Biology (Basel). 2024 Feb 28;13(3):154. doi: 10.3390/biology13030154. Biology (Basel). 2024. PMID: 38534424 Free PMC article.
-
Relapsing-remitting multiple sclerosis patients exhibit differential natural killer functional subpopulations.Acta Neurol Belg. 2024 Apr;124(2):603-610. doi: 10.1007/s13760-024-02488-y. Epub 2024 Mar 5. Acta Neurol Belg. 2024. PMID: 38441808 Free PMC article.
References
-
- Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, Wallstrom E, Lobell A, Brundin L, Lassmann H, Harris RA. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol. 2008;84:1248–1255. - PubMed
-
- Angelini DF, Borsellino G, Poupot M, Diamantini A, Poupot R, Bernardi G, Poccia F, Fournie JJ, Battistini L. FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood. 2004;104:1801–1807. - PubMed
-
- Araki M, Kondo T, Gumperz JE, Brenner MB, Miyake S, Yamamura T. Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int Immunol. 2003;15:279–288. - PubMed
-
- Aravalli RN, Peterson PK, Lokensgard JR. Toll-like receptors in defense and damage of the central nervous system. J Neuroimmune Pharmacol. 2007;2:297–312. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical